C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/475 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2652758
The invention relates to the use of 9-hydroxy ellipticine derivatives for the treatment of cancer. 9-hydroxy ellipticine derivatives may prove particularly useful for the treatment of metastatic cancers or cancers escaping conventional cytotoxic chemotherapies.
L'invention concerne l'utilisation des dérivés d'hydroxy-9 ellipticine pour le traitement du cancer. Les dérivés d'hydroxy-9 ellipticine peuvent se révéler particulièrement utiles pour le traitement des cancers métastatiques ou des cancers ne pouvant être traités par les chimiothérapies cytotoxiques conventionnelles.
Auclair Christian
Maksimenko Andrei
Polard Valerie
Bioalliance Pharma
Centre National de La Recherche Scientifique (c.n.r.s.)
Ecole Normale Superieure de Cachan
Robic
LandOfFree
Reversion of malignant phenotype with 9-hydroxy ellipticine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reversion of malignant phenotype with 9-hydroxy ellipticine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reversion of malignant phenotype with 9-hydroxy ellipticine... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1578914